SRTS vs. SSKN, ANIK, SGHT, NVRO, OSUR, TCMD, LUNG, ANGO, OBIO, and INO
Should you be buying Sensus Healthcare stock or one of its competitors? The main competitors of Sensus Healthcare include STRATA Skin Sciences (SSKN), Anika Therapeutics (ANIK), Sight Sciences (SGHT), Nevro (NVRO), OraSure Technologies (OSUR), Tactile Systems Technology (TCMD), Pulmonx (LUNG), AngioDynamics (ANGO), Orchestra BioMed (OBIO), and Inovio Pharmaceuticals (INO). These companies are all part of the "surgical & medical instruments" industry.
Sensus Healthcare (NASDAQ:SRTS) and STRATA Skin Sciences (NASDAQ:SSKN) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, community ranking, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk.
Sensus Healthcare currently has a consensus target price of $10.00, indicating a potential upside of 59.49%. STRATA Skin Sciences has a consensus target price of $38.00, indicating a potential upside of 1,037.72%. Given STRATA Skin Sciences' higher probable upside, analysts plainly believe STRATA Skin Sciences is more favorable than Sensus Healthcare.
In the previous week, STRATA Skin Sciences had 5 more articles in the media than Sensus Healthcare. MarketBeat recorded 7 mentions for STRATA Skin Sciences and 2 mentions for Sensus Healthcare. Sensus Healthcare's average media sentiment score of 0.98 beat STRATA Skin Sciences' score of 0.78 indicating that Sensus Healthcare is being referred to more favorably in the media.
Sensus Healthcare has higher earnings, but lower revenue than STRATA Skin Sciences. STRATA Skin Sciences is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.
Sensus Healthcare has a net margin of 14.70% compared to STRATA Skin Sciences' net margin of -34.92%. Sensus Healthcare's return on equity of 9.76% beat STRATA Skin Sciences' return on equity.
Sensus Healthcare has a beta of 1, indicating that its stock price has a similar volatility profile to the S&P 500.Comparatively, STRATA Skin Sciences has a beta of 1.41, indicating that its stock price is 41% more volatile than the S&P 500.
STRATA Skin Sciences received 44 more outperform votes than Sensus Healthcare when rated by MarketBeat users. However, 68.06% of users gave Sensus Healthcare an outperform vote while only 63.90% of users gave STRATA Skin Sciences an outperform vote.
25.3% of Sensus Healthcare shares are owned by institutional investors. Comparatively, 32.4% of STRATA Skin Sciences shares are owned by institutional investors. 11.1% of Sensus Healthcare shares are owned by insiders. Comparatively, 40.4% of STRATA Skin Sciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Summary
Sensus Healthcare beats STRATA Skin Sciences on 11 of the 18 factors compared between the two stocks.
Get Sensus Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for SRTS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Sensus Healthcare Competitors List
Related Companies and Tools
